Amitriptyline's Effect on Insulin and Weight

Mechanism of Weight Gain

Amitriptyline causes weight gain through multiple mechanisms, including effects on appetite regulation and possibly metabolic changes 2, 3
Within the tricyclic antidepressant class, amitriptyline specifically has been identified as having the highest association with weight gain compared to other tricyclics 1, 4
The weight gain effect appears to be dose-dependent and may become more significant with long-term use 5

The American Medical Association, as reported in the 2023 JAMA review on obesity management, specifically identifies amitriptyline as one of the antidepressants that promotes weight gain 5, 6
Clinicians should monitor patients on amitriptyline for unintentional weight gain, such as >2 kg in a month, or a ≥7% increase from baseline body weight 7

For patients with weight concerns, alternative antidepressants, such as SSRIs like fluoxetine and sertraline, should be considered when clinically appropriate, as they are associated with weight loss during short-term use and weight neutrality with long-term use 2
Bupropion is the only antidepressant consistently shown to promote weight loss 2
For patients who must remain on amitriptyline despite weight concerns, implementing dietary modifications and increased physical activity, considering adjunctive therapy with metformin or topiramate, and monitoring weight regularly can help counteract weight gain effects 7
Regular assessment for metabolic changes is also recommended for patients on amitriptyline 5

Among antidepressants, the weight gain potential varies significantly, with amitriptyline (tricyclic), paroxetine (SSRI), and mirtazapine having the highest risk 1, 2
Fluoxetine and sertraline have the lowest risk or are weight neutral, especially with long-term use 2
Bupropion has weight loss potential 2